Category: Uncategorized

Nov 19 2020

Uncategorized

Feinstein Institutes Researchers Help Lead $52M Study of Schizophrenia in High-Risk Youth

by Clinical Editor

No Comments

Researchers from The Feinstein Institutes for Medical Research and two other institutions have been awarded a $52 million, five-year grant from the National Institute of Mental Health (NIMH) to lead...

Nov 19 2020

Uncategorized

Abhishek Banerjee On Fighting His Own Demons And Battling With Mom’s Schizophrenia

by Clinical Editor

No Comments

Strong, muscular, tall, macho, suave – we wouldn’t blame you if you thought we were describing a man. The image associated with men has always inclined towards the physical aspect...

Nov 19 2020

Uncategorized

Parasite infection discovery could assist mental health treatments

by Clinical Editor

No Comments

New research into how a common parasite infection alters human behavior could help development of treatments for schizophrenia and other neurological disorders. T. gondii currently infects 2.5 billion people worldwide...

Nov 19 2020

Uncategorized

Rare and Possibly Life-Threatening Sensitivity to Key Schizophrenia Tx

by Clinical Editor

No Comments

A 22-year-old Hispanic man with schizophrenia is placed on an involuntary hold and admitted to an inpatient psychiatric unit in California after experiencing auditory, visual, and tactile …

Nov 19 2020

Uncategorized

Year in Review: Schizophrenia

by Clinical Editor

No Comments

In September, the American Psychiatric Association released new recommendations for treatment of schizophrenia– the first update since 2009. Although the guidelines reflect a shift towards shared …

Nov 18 2020

Uncategorized

Alkermes flops FDA’s ‘remote review’ at manufacturing site for schizophrenia, bipolar disorder drug – FiercePharma

by Clinical Editor

No Comments

Alkermes flops FDA’s ‘remote review’ at manufacturing site for schizophrenia, bipolar disorder drug  FiercePharma U.S. FDA declines to approve Alkermes’ schizophrenia treatment  Reuters Alkermes’ schizophrenia, bipolar I candidate draws manufacturing CRL |...

Nov 18 2020

Uncategorized

Global Schizophrenia Market to 2030 – Insights, Epidemiology and Market Forecast – ResearchAndMarkets.com

by Clinical Editor

No Comments

Market Insights, Epidemiology and Market Forecast – 2030″ drug pipelines has been added to ResearchAndMarkets.com’s offering.

Nov 18 2020

Uncategorized

Feinstein Institutes Researchers Help Lead $52M Study of Schizophrenia in High-Risk Youth

by Clinical Editor

No Comments

Researchers from The Feinstein Institutes for Medical Research and two other institutions have been awarded a $52 million, five-year grant from the National Institute of Mental Health (NIMH) to lead...

Nov 18 2020

Uncategorized

Rare and Possibly Life-Threatening Sensitivity to Key Schizophrenia Tx

by Clinical Editor

No Comments

A 22-year-old Hispanic man with schizophrenia is placed on an involuntary hold and admitted to an inpatient psychiatric unit in California after experiencing auditory, visual, and tactile …

Nov 18 2020

Uncategorized

U.S. FDA declines to approve Alkermes’ schizophrenia treatment

by Clinical Editor

No Comments

The U.S. Food and Drug Administration has declined to approve Alkermes’ treatment for schizophrenia and bipolar disorder, the drugmaker said on Tuesday.